ES535842A0 - Un procedimiento para preparar octapeptidos lineales - Google Patents

Un procedimiento para preparar octapeptidos lineales

Info

Publication number
ES535842A0
ES535842A0 ES535842A ES535842A ES535842A0 ES 535842 A0 ES535842 A0 ES 535842A0 ES 535842 A ES535842 A ES 535842A ES 535842 A ES535842 A ES 535842A ES 535842 A0 ES535842 A0 ES 535842A0
Authority
ES
Spain
Prior art keywords
procedure
octapeptides
preparing linear
vasopressin
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES535842A
Other languages
English (en)
Other versions
ES8600216A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of ES8600216A1 publication Critical patent/ES8600216A1/es
Publication of ES535842A0 publication Critical patent/ES535842A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES535842A 1983-02-16 1984-09-12 Un procedimiento para preparar octapeptidos lineales Granted ES535842A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/467,117 US4469679A (en) 1983-02-16 1983-02-16 Octapeptide vasopressin antagonists

Publications (2)

Publication Number Publication Date
ES8600216A1 ES8600216A1 (es) 1985-10-01
ES535842A0 true ES535842A0 (es) 1985-10-01

Family

ID=23854436

Family Applications (2)

Application Number Title Priority Date Filing Date
ES529738A Expired ES8606408A1 (es) 1983-02-16 1984-02-15 Un procedimiento para preparar octapeptidos antagonistas de vasopresina
ES535842A Granted ES535842A0 (es) 1983-02-16 1984-09-12 Un procedimiento para preparar octapeptidos lineales

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES529738A Expired ES8606408A1 (es) 1983-02-16 1984-02-15 Un procedimiento para preparar octapeptidos antagonistas de vasopresina

Country Status (20)

Country Link
US (2) US4469679A (es)
EP (1) EP0119705B1 (es)
JP (1) JPS59155348A (es)
KR (1) KR850001230A (es)
AT (1) ATE46174T1 (es)
AU (1) AU577778B2 (es)
DE (1) DE3479664D1 (es)
DK (1) DK65284A (es)
ES (2) ES8606408A1 (es)
FI (1) FI840577A (es)
GR (1) GR81786B (es)
HU (1) HU196227B (es)
IE (1) IE56859B1 (es)
IL (1) IL70944A (es)
NO (1) NO840563L (es)
NZ (1) NZ207106A (es)
PH (1) PH20076A (es)
PT (1) PT78094B (es)
ZA (1) ZA841104B (es)
ZW (1) ZW1884A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2708547A (en) * 1950-07-19 1955-05-17 Semt Exhaust gas turbo-blowers for high supercharging rates and method of mounting same
US4714696A (en) * 1984-01-26 1987-12-22 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
US4649130A (en) * 1984-01-26 1987-03-10 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
US4599324A (en) * 1984-11-21 1986-07-08 Smithkline Beckman Corporation V1-vasopressin antagonists
US4684716A (en) * 1984-12-14 1987-08-04 Smithkline Beckman Corporation Polypeptide intermediates
US4624943A (en) * 1985-03-20 1986-11-25 Smithkline Beckman Corporation Aromatic basic-tailed vasopressin antagonists
US4656248A (en) * 1985-04-23 1987-04-07 Smithkline Beckman Corporation Cupric oxidation of 1,6-dimercapto-containing peptides
US4711877A (en) * 1985-09-18 1987-12-08 Smithkline Beckman Corporation 6-pen-vasopressin compounds
US4742154A (en) * 1985-10-23 1988-05-03 Smithkline Beckman Corporation GLN- or ASN-vasopressin compounds
US4687758A (en) * 1985-11-19 1987-08-18 Smithkline Beckman Corporation Des-proline-N-methylarginine vasopressins
US4760052A (en) * 1986-01-16 1988-07-26 Smithkline Beckman Corporation 1,6-dicarba-vasopressin compounds
US4876243A (en) * 1986-02-25 1989-10-24 Smithkline Beckman Corporation Vasopressin compounds
US4717715A (en) * 1986-06-23 1988-01-05 Smithkline Beckman Corporation ARG7 -ARG8 -vasopressin antagonists
US4724229A (en) * 1986-09-30 1988-02-09 Smithkline Beckman Corporation Arg-arg-arg-vasopressin antagonists
US4766108A (en) * 1986-12-04 1988-08-23 Smith Kline Beckman Corporation Tyr-Arg-vasopressin antagonists
US4826813A (en) * 1987-05-21 1989-05-02 Smithkline Beckman Corporation 4'-Methyl-β-mercapto-β,β-cyclopentamethylenepropionic acid vasopressin antagonists
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
JP2542241B2 (ja) * 1988-08-12 1996-10-09 富士レビオ株式会社 ペプチド
US5051400A (en) * 1990-06-28 1991-09-24 Smithkline Beecham Corporation Method of treating nausea and emesis related to motion sickness with vasopressin antagonists
US6759384B1 (en) 1994-04-26 2004-07-06 Aventis Pharmaceuticals Inc. Factor Xa inhibitors
US5849510A (en) * 1994-04-26 1998-12-15 Selectide Corporation Factor Xa inhibitors
JP3655632B2 (ja) * 1994-04-26 2005-06-02 アベンティス・ファーマスーティカルズ・インコーポレイテッド 第Ｘａ因子インヒビター
US6001809A (en) * 1994-07-11 1999-12-14 Elan Pharmaceuticals, Inc. Inhibitors of leukocyte adhesion
EP1950224A3 (en) * 1998-03-09 2008-12-17 Zealand Pharma A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1246055A (en) * 1980-03-24 1988-12-06 Joseph H. Cort N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs
US4367225A (en) * 1981-03-24 1983-01-04 The Medical College Of Ohio Novel antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin
US4399125A (en) * 1981-03-24 1983-08-16 Maurice Manning Novel antagonists of the antidiuretic action of arginine vasopressin
US4643520A (en) * 1983-03-10 1987-02-17 Allied Corporation Method of terminating fiber optic connector without polishing optical fiber

Also Published As

Publication number Publication date
ZA841104B (en) 1985-04-24
NZ207106A (en) 1990-12-21
PT78094A (en) 1984-03-01
IE56859B1 (en) 1992-01-01
JPS59155348A (ja) 1984-09-04
FI840577A (fi) 1984-08-17
AU2453484A (en) 1984-08-23
ATE46174T1 (de) 1989-09-15
ES8600216A1 (es) 1985-10-01
IE840352L (en) 1984-08-16
DE3479664D1 (en) 1989-10-12
HUT34042A (en) 1985-01-28
PT78094B (en) 1986-05-20
FI840577A0 (fi) 1984-02-14
EP0119705A2 (en) 1984-09-26
IL70944A (en) 1990-11-29
EP0119705A3 (en) 1987-04-22
KR850001230A (ko) 1985-03-16
ES8606408A1 (es) 1986-04-01
US4542124A (en) 1985-09-17
ES529738A0 (es) 1986-04-01
HU196227B (en) 1988-10-28
NO840563L (no) 1984-08-17
AU577778B2 (en) 1988-10-06
PH20076A (en) 1986-09-18
GR81786B (es) 1984-12-12
EP0119705B1 (en) 1989-09-06
DK65284A (da) 1984-08-17
IL70944A0 (en) 1984-05-31
US4469679A (en) 1984-09-04
ZW1884A1 (en) 1984-05-30
DK65284D0 (da) 1984-02-14

Similar Documents

Publication Publication Date Title
ES535842A0 (es) Un procedimiento para preparar octapeptidos lineales
BG43007A3 (en) Method for preparing n- (bicyclo- hetero- cyclyl)- 4- piperidinamines
EP0182372A3 (en) New factor viii coagulant polypeptides
MY125555A (en) Heptapeptide oxytocin analogues
DE3587016D1 (de) Nona- und dekapeptidanaloga von lhrh, welche als lhrh-antagonisten dienen.
DK0738280T3 (da) Antagonist til vasoaktivt tarmpolypeptid (VTP)
ATE63750T1 (de) Peptid, dessen herstellung und benutzung.
GB1440859A (en) Vasopressin-type hormones and a method for their preparation
ES2121088T3 (es) Analogos de peptidos limitados conformacionalmente como agentes antiplaquetarios.
JO1362B1 (en) Antagonists that do not contain proline unit and have the effectiveness of vasopressin compounds
EP0225109A3 (en) Vasopressin antagonists
EP0234935A3 (en) Vasopressin compounds
DE3682368D1 (de) Mitogene peptide.
ES8800271A1 (es) Un procedimiento para preparar heptapeptidos ciclicos basicos y aromaticos.
SE8704272L (sv) Pharmaceutisk komposition
ATE110385T1 (de) Derivate von aminocarboxylsäure.

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506